1.PT, APTT, FIB, TT, D-Dimer, FDP, AT-III.Lwm yam tsis ntev los no.
2.Draft kws sau ntawv ntawm Tuam Tshoj National D-Dimer tus qauv "27 YYT 1240-2014, Tuam Tshoj National Pharmaceutical kev lag luam tus qauv ntawm D-Dimer reagent (kit)".
3.D-Dimer NPV> = 97%, tuaj yeem txiav tawm VTE nrog kev kuaj mob.
4.Ua raws li Hemostasis tov nrog Succeeder coagulation ntsuas, consumables, thov kev pab txhawb nqa.
1. Ntev: tuaj yeem pom nyob rau hauv hemophilia A, hemophilia B, kab mob siab, plab hnyuv sterilization syndrome, qhov ncauj anticoagulants, diffuse intravascular coagulation, mob hemophilia;FXI, FXII deficiency;ntshav Anticoagulant tshuaj (coagulation yam inhibitors, lupus anticoagulants, warfarin los yog heparin) nce;ntau cov ntshav khaws cia tau hloov pauv.
2. Shorten: Nws tuaj yeem pom hauv lub xeev hypercoagulable, kab mob thromboembolic, thiab lwm yam.
Kev siv ntau yam ntawm tus nqi ib txwm muaj
Qhov ib txwm siv tus nqi ntawm lub sijhawm ua haujlwm ib nrab thromboplastin (APTT): 27-45 vib nas this.
TT yog hais txog lub sijhawm ntshav txhaws tom qab ntxiv cov txheej txheem thrombin rau cov ntshav ntshav.Nyob rau hauv txoj kev sib txuam coagulation, cov thrombin generated hloov fibrinogen rau hauv fibrin, uas tuaj yeem cuam tshuam los ntawm TT.Vim tias fibrin (proto) degradation cov khoom (FDP) tuaj yeem txuas ntxiv TT, qee tus neeg siv TT raws li kev tshuaj ntsuam xyuas rau fibrinolytic system.
Daim npav ua lag luam
Suav WeChat
Lus Askiv WeChat